Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market. The post Why One Healthcare Founder…
[Sponsored] The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times. The post How to Optimize Your Phlebotomy Setup for Efficient Patient Care appeared first on MedCity News.
How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?” The post Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.
When was the last time you asked a patient to contribute to trial design? Have you ever asked a patient to contribute to a protocol? Patient-centricity benefits the entire healthcare ecosystem. The post When Patients Win, Everyone Wins appeared first on MedCity News.
Trellis Health emerged from stealth and announced $1.8 million in pre-seed funding. The platform helps women easily access and understand their medical records so they can make better health decisions during pregnancy and throughout their lives. The post New Pregnancy App Launches to Support Mothers Through Birth and Beyond appeared first on MedCity News.
In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection for remote monitoring technologies. The post Peterson Center on Healthcare: 3 Policy Recommendations for Remote Health Technologies appeared first on MedCity News.
The first Phase 3 results for Eli Lilly’s daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The pharmaceutical giant plans global regulatory submissions starting at the end of this year. The post Eli Lilly’s Metabolic Medicine Takes the Lead in the Race to Develop…
Healthcare organizations need to jump in with both feet when it comes to AI, as mitigating risk is quickly becoming an existential business issue. Machine learning has quickly gone from being a nice-to-have to a must-have. The post Health Plans Can Reduce Costs with a Focus on Rising Risk appeared first on MedCity News.
The self-medicating plant movement sits at the intersection of empowerment and misinformation. On one hand, it signals a growing desire for agency in personal health. On the other, it raises alarms about safety, oversight, and the risk of delayed care. The post The Rise of Plant-Based Self-Medication and What Healthcare Must Do Next appeared first…
Glycomine’s lead program is an experimental treatment for PMM2-CDG, an ultra-rare enzyme deficiency often misdiagnosed as cerebral palsy. With encouraging results from an open-label Phase 2 study, the biotech startup is now preparing for a placebo-controlled test that could potentially support a regulatory submission. The post Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare…